Home/Filings/4/0001012975-17-000478
4//SEC Filing

Altimmune, Inc. 4

Accession 0001012975-17-000478

$ALTCIK 0001326190operating

Filed

Jun 7, 8:00 PM ET

Accepted

Jun 8, 4:26 PM ET

Size

5.4 KB

Accession

0001012975-17-000478

Insider Transaction Report

Form 4
Period: 2017-06-06
Tasker Sybil
Chief Medical Officer
Transactions
  • Award

    Stock Options (option to buy)

    2017-06-06+40,00040,000 total
    Exercise: $4.12Exp: 2027-06-06Common Stock, par value $0.0001 (40,000 underlying)
Footnotes (1)
  • [F1]The option vests and becomes exercisable in four equal annual installments commencing on the first anniversary of the date of grant.

Issuer

Altimmune, Inc.

CIK 0001326190

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001326190

Filing Metadata

Form type
4
Filed
Jun 7, 8:00 PM ET
Accepted
Jun 8, 4:26 PM ET
Size
5.4 KB